Clostridium Infections Clinical Trial
Official title:
An Observational Study in Adults With Clostridioides Difficile Infection to Determine the Feasibility and Logistics of Biospecimen Collection, Transportation and Testing at Select US Study Sites
D8820C00001 is an exploratory, non-interventional, unblinded, observational study evaluating the acceptability, feasibility and performance of methods to collect, transport and test biospecimens in participants ≥ 18 years of age with an active CDI. Participants will also be monitored for recurring episodes of diarrhea and will need to complete validated PROs and study evaluation questionnaires
The premise of D8820C00001 study is to monitor participants for recurring episodes of diarrhea and evaluate acceptability and feasibility of the use of the digital tools and patient outcome measures. The aim will be to enroll two cohorts of patients; the first will be the Monitoring cohort, enrolling a targeted minimum of 20 and a maximum of 100 participants who will be followed through Day 42, with a screening period from Day -5 to Day 1 (see Section 2.1.1). The second will be the Discard Stool cohort, enrolling up to 200 participants, who will not be followed during the study but who will provide consent for the use of any discarded stool specimens that will not be used for additional laboratory diagnostic testing . ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04179201 -
Study on Clostridium Difficile Infection in Chinese Patients With Inflammatory Bowel Disease
|
||
| Completed |
NCT02563106 -
A Study of SYN-004 for the Prevention of C.Diff in Patients With a LRTI
|
Phase 2 | |
| Completed |
NCT00214461 -
Safety, Tolerability, and Immunogenicity of a Clostridium Difficile Toxoid Vaccine in Healthy Elderly Volunteers
|
Phase 1 | |
| Completed |
NCT00314951 -
Fidaxomicin Versus Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhea (CDAD)
|
Phase 3 | |
| Completed |
NCT00328263 -
Efficacy and Safety of BIO-K + CL1285 in Prevention of Antibiotic-associated Diarrhea in Hospitalized Adult Patients
|
Phase 3 | |
| Completed |
NCT00127803 -
Safety, Tolerability, and Immunogenicity Study of a Clostridium Difficile Toxoid Vaccine in Healthy Adult Volunteers
|
Phase 1 | |
| Completed |
NCT00350298 -
Study of the Clinical Effectiveness of a Human Monoclonal Antibody to C. Difficile Toxin A and Toxin B in Patients With Clostridium Difficile Associated Disease
|
Phase 2 | |
| Withdrawn |
NCT05077085 -
Bezlotoxumab Versus FMT for Multiple Recurrent CDI
|
Phase 4 | |
| Recruiting |
NCT02681068 -
MicroTrans - A Multicenter Registry of Fecal Microbiota Transplantation
|
N/A | |
| Completed |
NCT00446355 -
Clinical Outcomes of Patients With Clostridium Difficile Associated Disease Attributable to Diverse tcdC Genotypes
|
N/A | |
| Terminated |
NCT00384527 -
Study of Nitazoxanide in the Treatment of Clostridium Difficile-associated Disease
|
Phase 3 | |
| Completed |
NCT00269399 -
A Trial to Compare Xifaxan to Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhea (CDAD)
|
Phase 3 | |
| Completed |
NCT04026009 -
Safety and Immunogenicity Study of GSK's Clostridium Difficile Vaccine 2904545A When Administered in Healthy Adults Aged 18-45 Years and 50-70 Years
|
Phase 1 | |
| Completed |
NCT00468728 -
PAR-101/OPT-80 Versus Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhea (CDAD)
|
Phase 3 |